The ever growing story of cyclo-oxygenase inhibition

被引：22

作者：

Garcia Rodriguez, Luis Alberto ^{[1
]}

Patrignani, Paola

机构：

[1] Ctr Espanol Invest Farmacoepidemiol, Madrid 28004, Spain

[2] Univ G DAnnunzio, Sch Med, Dept Med, Chieti, Italy

[3] Univ G DAnnunzio, Sch Med, Ctr Excellence Aging, Chieti, Italy

来源：

LANCET | 2006年 / 368卷 / 9549期

关键词：

D O I：

10.1016/S0140-6736(06)69667-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1745 / 1747

页数：3

共 13 条

[1]

CANNON CP, 2006, LANCET 1113, DOI DOI 10.1016/S0140-6736(06)69666-9

[2] Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects [J].

Capone, ML ;

Tacconelli, S ;

Sciulli, MG ;

Grana, M ;

Ricciotti, E ;

Minuz, P ;

Di Gregorio, P ;

Merciaro, G ;

Patrono, C ;

Patrignani, P .

CIRCULATION, 2004, 109 (12) :1468-1471

[3] Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects [J].

Capone, ML ;

Sciulli, MG ;

Tacconelli, S ;

Grana, M ;

Ricciotti, E ;

Renda, G ;

Di Gregorio, P ;

Merciaro, G ;

Patrignani, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1295-1301

[4] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].

Catella-Lawson, F ;

Reilly, MP ;

Kapoor, SC ;

Cucchiara, AJ ;

DeMarco, S ;

Tournier, B ;

Vyas, SN ;

FitzGerald, GA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817

[5]

*EUR MED AG, 2006, CHMP REV NONS NONST

[6] Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. [J].

FitzGerald, GA ;

Patrono, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :433-442

[7] Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].

Grosser, T ;

Fries, S ;

FitzGerald, GA .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15

[8] Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction [J].

Hernández-Díaz, S ;

Varas-Lorenzo, C ;

Rodríguez, LAG .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) :266-274

[9] Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials [J].

Kearney, Patricia M. ;

Baigent, Colin ;

Godwin, Jon ;

Halls, Heather ;

Emberson, Jonathan R. ;

Patrono, Carlo .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553) :1302-1305

[10] Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2 [J].

McAdam, BF ;

Catella-Lawson, F ;

Mardini, IA ;

Kapoor, S ;

Lawson, JA ;

FitzGerald, GA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :272-277

← 1 2 →